Deal marks Fund's first investment in Europe and advances its mission of enabling the launch of two to four antimicrobials by 2030

BOSTON, Jan. 5, 2023 /PRNewswire/ --  The AMR Action Fund, the world's largest public-private partnership investing in biotech companies that are developing antimicrobials, announced today that it has invested in...